PDCD1 and cancer: Imaging was performed with a 42-antibody panel designed to detect cancer phenotypic markers (e.g., PD-L1, H2Kb, H2Db, and Ki67); immune cell-type-defining markers (e.g., CD3, CD4, CD8, and F4/80); and functional markers (e.g., PD-1 and CD27).59